Literature DB >> 23580126

Sociodemographic determinants in preventive tests for cardiovascular diseases in a representative sample of the adult Greek population.

Georgia Pallikarona1, Chara Tzavara, Christine Dimitrakaki, Yannis Tountas.   

Abstract

OBJECTIVES: The purpose of the current study is to investigate the use of preventive healthcare services by the adult Greek population and the factors that determine such use.
METHODS: Data were obtained from a national household survey (Hellas Health I) conducted during 2006. The survey population consisted of 1,005 individuals, with a mean age of 47.4 years. Candidate respondents were selected by means of a three-stage, proportional to size, sampling design. Chi-square tests and logistic regression analyses were used (p < 0.05).
RESULTS: Among the determinants of performance of screening tests, gender, age, marital status, the presence of chronic illness and self-reported health status and the use of a family doctor play an important role.
CONCLUSIONS: According to the findings of our study, screening tests are performed in a low percentage of the Greek population, even for individuals at increased risk for cardiovascular disease. It is obvious that doctors should focus more on such population groups, while national health policies promoting screening tests and prevention in general are warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23580126     DOI: 10.1007/s40292-013-0005-4

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  23 in total

1.  What factors hinder women of color from obtaining preventive health care?

Authors:  Llewellyn J Cornelius; Pamela L Smith; Gaynell M Simpson
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

Review 2.  Root causes of violent conflict in developing countries.

Authors:  Frances Stewart
Journal:  BMJ       Date:  2002-02-09

Review 3.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

Review 4.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

5.  The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study.

Authors:  Charity D Evans; Dean T Eurich; Jeff G Taylor; David F Blackburn
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

6.  Preventive screening. What factors influence testing?

Authors:  Murray M Finkelstein
Journal:  Can Fam Physician       Date:  2002-09       Impact factor: 3.275

7.  Preventive care and continuity of attendance. Is there a risk?

Authors:  I D Steven; E Dickens; S A Thomas; C Browning; E Eckerman
Journal:  Aust Fam Physician       Date:  1998-01

8.  State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s.

Authors:  David E Nelson; Shayne Bland; Eve Powell-Griner; Richard Klein; Henry E Wells; Gary Hogelin; James S Marks
Journal:  JAMA       Date:  2002 May 22-29       Impact factor: 56.272

9.  Expenditures associated with preventive healthcare.

Authors:  Matthew G Marin; Jessica Nutik Zitter
Journal:  Prev Med       Date:  2004-11       Impact factor: 4.018

10.  Sex differences in illness incidence, prognosis and mortality: issues and evidence.

Authors:  I Waldron
Journal:  Soc Sci Med       Date:  1983       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.